Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.
- DOI
- 10.1158/2767-9764.crc-25-0633
- Published
- 2026 Mar 1
- Container
- Cancer research communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2767-9764.crc-25-0633,
title = {Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.},
author = {Chan SL and Yau T and Kelley RK and Finn RS and Yoo C and Furuse J and Ren Z and Klümpen HJ and Ozaka M and Pelzer U and Arslan C and Park JO and Edeline J and Valle JW and Ueno M and Vogel A and Starkopf L and Malhotra U and Siegel AB and Qin S},
year = {2026},
journal = {Cancer research communications},
doi = {10.1158/2767-9764.crc-25-0633},
url = {https://doi.org/10.1158/2767-9764.crc-25-0633}
}RIS
TY - JOUR TI - Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study. AU - Chan SL AU - Yau T AU - Kelley RK AU - Finn RS AU - Yoo C AU - Furuse J AU - Ren Z AU - Klümpen HJ AU - Ozaka M AU - Pelzer U AU - Arslan C AU - Park JO AU - Edeline J AU - Valle JW AU - Ueno M AU - Vogel A AU - Starkopf L AU - Malhotra U AU - Siegel AB AU - Qin S PY - 2026 JO - Cancer research communications DO - 10.1158/2767-9764.crc-25-0633 UR - https://doi.org/10.1158/2767-9764.crc-25-0633 ER -
APA
SL, C., T, Y., RK, K., RS, F., C, Y., J, F., Z, R., HJ, K., M, O., U, P., C, A., JO, P., J, E., JW, V., M, U., A, V., L, S., U, M., AB, S., & S, Q. (2026). Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-25-0633
Source records
- pubmed · retrieved 2026-09-26T01:24:38.563Z
- europe-pmc · retrieved 2026-09-26T01:24:38.577Z